These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 8641815)
1. Mass transfer limitations to the performance of membrane bioartificial liver support devices. Catapano G Int J Artif Organs; 1996 Jan; 19(1):18-35. PubMed ID: 8641815 [TBL] [Abstract][Full Text] [Related]
2. Assessment of bioartificial liver support in acute liver failure. Hughes RD; Williams R Int J Artif Organs; 1996 Jan; 19(1):3-6. PubMed ID: 8641816 [No Abstract] [Full Text] [Related]
3. Role of transport proteins in bioartificial liver assist systems. Mitzner S; Stange J; Freytag J; Lindemann S; Schmidt R Int J Artif Organs; 1996 Jan; 19(1):49-52. PubMed ID: 8641819 [No Abstract] [Full Text] [Related]
4. Hepatocyte encapsulation--initial intentions and new aspects for its use in bioartificial liver support. Stange J; Mitzner S Int J Artif Organs; 1996 Jan; 19(1):45-8. PubMed ID: 8641818 [No Abstract] [Full Text] [Related]
5. Cell sources for bioartificial liver support. Stange J; Mitzner S Int J Artif Organs; 1996 Jan; 19(1):14-7. PubMed ID: 8641814 [TBL] [Abstract][Full Text] [Related]
6. Use of bioartificial and artificial liver support devices. Hughes RD; Williams R Semin Liver Dis; 1996 Nov; 16(4):435-44. PubMed ID: 9027956 [TBL] [Abstract][Full Text] [Related]
11. Metabolic activity and clinical efficacy of animal and human hepatocytes in bioartificial support systems for acute liver failure. Riordan SM; Skouteris GG; Williams R Int J Artif Organs; 1998 Jun; 21(6):312-8. PubMed ID: 9714023 [No Abstract] [Full Text] [Related]
12. Bioartificial liver support: developments in hepatocyte culture and bioreactor design. Riordan S; Williams R Br Med Bull; 1997; 53(4):730-44. PubMed ID: 9536524 [TBL] [Abstract][Full Text] [Related]
13. Hepatic assist devices: will they ever be successful? Sussman NL; McGuire BM; Kelly JH Curr Gastroenterol Rep; 2009 Feb; 11(1):64-8. PubMed ID: 19166661 [TBL] [Abstract][Full Text] [Related]
14. Immunological consequences of the use of xenogeneic hepatocytes in a bioartificial liver for acute liver failure. te Velde AA; Flendrig LM; Ladiges NC; Chamuleau RA Int J Artif Organs; 1997 Apr; 20(4):229-33. PubMed ID: 9195241 [TBL] [Abstract][Full Text] [Related]
15. [Cell community: regulation of cell-substratum interaction for bioartificial organs]. Akaike T Tanpakushitsu Kakusan Koso; 1993 May; 38(7):1345-53. PubMed ID: 8337403 [No Abstract] [Full Text] [Related]
17. Acute liver failure: liver support therapies. Stadlbauer V; Jalan R Curr Opin Crit Care; 2007 Apr; 13(2):215-21. PubMed ID: 17327745 [TBL] [Abstract][Full Text] [Related]
18. The promise of artificial liver replacement. Pryor HI; Vacanti JP Front Biosci; 2008 Jan; 13():2140-59. PubMed ID: 17981698 [TBL] [Abstract][Full Text] [Related]
19. Development of a bioartificial liver using isolated hepatocytes. Dixit V Artif Organs; 1994 May; 18(5):371-84. PubMed ID: 8037612 [TBL] [Abstract][Full Text] [Related]
20. Extracorporeal support and hepatocyte transplantation in acute liver failure and cirrhosis. Riordan SM; Williams R J Gastroenterol Hepatol; 1999 Aug; 14(8):757-70. PubMed ID: 10482426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]